Table 1 Anthropometric data and comorbidities at baseline of the 130 patients who had been contacted at 3 months of follow-up, data is from the analysis on February 28 th 2013
Baseline data | n | % |
|---|---|---|
Patients contacted | 130 | |
Sex m/f | 55/75 | 42.3%/57.7% |
Mean | +/-SD | |
Age (years) | 65.7 | 17.0 |
Height (cm) | 170 | 9.5 |
Weight (kg) | 82.5 | 17.2 |
BMI (kg/m2) | 28.6 | 5.4 |
Comorbidities | n | % |
Arterial hypertension | 55 | 42.3 |
Coronary artery disease | 11 | 8.5 |
Atrial fibrillation/flutter | 19 | 14.6 |
Heart valve pathology | 8 | 6.2 |
COPD | 10 | 7.7 |
Asthma | 8 | 6.2 |
Interstitial lung disease | 6 | 4.6 |
Sleep related breathing disorder | 11 | 8.5 |
Alveolar hypoventilation | 1 | 0.8 |
Diabetes | 15 | 11.5 |
Chronic kidney disease | 9 | 6.9 |
Liver disease | 6 | 4.6 |
Thyroid disorder/Struma | 25 | 19.2 |
Rheumatism/collagen vascular disease | 7 | 5.4 |